AI assistant
Sending…
NEOGEN CORP — Director's Dealing 2024
Feb 9, 2024
32081_dirs_2024-02-09_ab926a9e-0092-4f2e-9646-2b6e872e822f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: NEOGEN CORP (NEOG)
CIK: 0000711377
Period of Report: 2023-10-26
Reporting Person: Naemura David H. (CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-10-26 | Common Stock (Right to Buy) | $15.48 | A | 179550 | Acquired | 2030-10-26 | Common Stock (179550) | Direct |
| 2023-10-26 | Common Stock (Right to Buy) | $15.48 | A | 379747 | Acquired | 2030-10-26 | Common Stock (379747) | Direct |
| 2023-10-26 | Restricted Stock Units | $15.48 | A | 46512 | Acquired | 2026-10-26 | Common Stock (46512) | Direct |
Footnotes
F1: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants
F2: See Form 8-K filed 10.31.23 for description of option. Number of units derived from Monte Carlo valuation model
More from NEOGEN CORP
Regulatory Filings
2026
May 20
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 20
Interim / Quarterly Report
2026
Apr 9
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Mar 30
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 17